News Focus
News Focus
Replies to #73364 on Biotech Values
icon url

DewDiligence

02/03/11 5:32 PM

#114005 RE: DewDiligence #73364

Mind boggling: VRTX expects its cumulative NOL’s at the time of the US Telaprevir launch to exceed $3B. (Source: VRTX’s 4Q10 CC)